Current News

Print version | PDF version | Send article | RSS-Feed

A-Bio Secures Major Deal with Novo Nordisk

01 Jun 2005 - A-Bio Pharma Pte Ltd (A-Bio) announced that it has entered into a multi-year Master Service Agreement with Novo Nordisk A/S. Under the agreement, Novo Nordisk will engage A-Bio for process development and GMP clinical supply of biologics in its pipeline of biopharmaceutical projects.
 
"We are delighted by this exciting, multi-product collaboration with Novo Nordisk, a world leader in diabetes care," said Dr George Wang, Managing Director of A-Bio. "Securing yet another international biopharmaceutical company as our long term partner is a substantial step towards strengthening our global customer base. This deal further reinforces A-Bio's position in Asia as a leading biologics contract manufacturer."